Kuros Biosciences Ltd. (CSBTF)
26.99
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Kuros Biosciences Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2013 | 184.57 |
| March 27, 2013 | 184.57 |
| March 26, 2013 | 184.57 |
| March 25, 2013 | 184.57 |
| March 22, 2013 | 184.57 |
| March 21, 2013 | 184.57 |
| March 20, 2013 | 184.57 |
| March 19, 2013 | 184.57 |
| March 18, 2013 | 184.57 |
| March 15, 2013 | 184.57 |
| March 14, 2013 | 184.57 |
| March 13, 2013 | 184.57 |
| March 12, 2013 | 184.57 |
| March 11, 2013 | 184.57 |
| March 08, 2013 | 184.57 |
| March 07, 2013 | 184.57 |
| March 06, 2013 | 184.57 |
| March 05, 2013 | 184.57 |
| March 04, 2013 | 184.57 |
| March 01, 2013 | 184.57 |
| February 28, 2013 | 184.57 |
| February 27, 2013 | 184.57 |
| February 26, 2013 | 184.57 |
| February 25, 2013 | 184.57 |
| February 22, 2013 | 184.57 |
| Date | Value |
|---|---|
| February 21, 2013 | 184.57 |
| February 20, 2013 | 184.57 |
| February 19, 2013 | 184.57 |
| February 15, 2013 | 184.57 |
| February 14, 2013 | 184.57 |
| February 13, 2013 | 184.57 |
| February 12, 2013 | 184.57 |
| February 11, 2013 | 184.57 |
| February 08, 2013 | 184.57 |
| February 07, 2013 | 184.57 |
| February 06, 2013 | 184.57 |
| February 05, 2013 | 184.57 |
| February 04, 2013 | 184.57 |
| February 01, 2013 | 184.57 |
| January 31, 2013 | 184.57 |
| January 30, 2013 | 184.57 |
| January 29, 2013 | 184.57 |
| January 28, 2013 | 201.43 |
| January 25, 2013 | 201.43 |
| January 24, 2013 | 201.43 |
| January 23, 2013 | 201.43 |
| January 22, 2013 | 201.43 |
| January 18, 2013 | 201.43 |
| January 17, 2013 | 201.43 |
| January 16, 2013 | 201.43 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Molecular Partners AG | 2.465 |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 7.996 |
| AC Immune SA | 5.600 |
Price to Book Value Related Metrics
| PE Ratio | 120.49 |
| PS Ratio | 6.178 |
| Price | 26.99 |
| Earnings Yield | 0.83% |
| Market Cap | 1.065B |
| Operating PE Ratio | 102.89 |
| Normalized PE Ratio | 120.49 |